prostatic adenocarcinoma
Showing 1 - 25 of 3,777
Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)
Not yet recruiting
- Prostatic Adenocarcinoma
-
Seoul, Korea, Korea, Republic ofSamsung Medical Center
Aug 23, 2023
Metastatic Prostatic Adenocarcinoma Trial in Lancaster, Rochester (Opdivo Injectable Product, Yervoy Injectable Product,
Completed
- Metastatic Prostatic Adenocarcinoma
- Opdivo Injectable Product
- +3 more
-
Lancaster, California
- +1 more
Jun 15, 2022
Prostatic Tumor Trial in Seoul (Docetaxel, Androgen-Deprivation Therapy (ADT))
Active, not recruiting
- Prostatic Neoplasm
- Docetaxel
- Androgen-Deprivation Therapy (ADT)
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 6, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))
Active, not recruiting
- Prostate Cancer
- +5 more
- 131I-PSMA-1095 Radioligand Therapy (RLT)
-
Montreal, Quebec, CanadaStephan Probst
Oct 24, 2022
Prostatic Tumors, Prostate Cancer, Prostate Adenocarcinoma Trial run by the National Cancer Institute (NCI) (18F-DCFPyL,
Not yet recruiting
- Prostatic Neoplasms
- +2 more
- 18F-DCFPyL
- Stereotactic Body Radiation Therapy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)
Not yet recruiting
- Prostate Cancer
- +4 more
- Olaparib
- LHRH agonist
- (no location specified)
Aug 10, 2022
Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)
Active, not recruiting
- Adenocarcinoma of the Prostate
- Androgen suppression plus radiation therapy
-
Montreal, Quebec, Canada
- +1 more
Jan 30, 2023
Prostatic Adenocarcinoma and Its Clinicopathological Features
Not yet recruiting
- Prostate Adenocarcinoma
- Immunohistochemistry of prostate biopsy
- (no location specified)
Mar 30, 2021
Adding MR Fusion to Standard US Guided Prostate Biopsy
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- TRUS biopsy
-
Tucson, ArizonaUniversity of Arizona
Jan 27, 2023
Prostate Cancer, Prostatic Adenocarcinoma Trial in New York (degarelix injection, androgen deprivation therapy)
Active, not recruiting
- Prostate Cancer
- Prostatic Adenocarcinoma
- degarelix injection
- androgen deprivation therapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 28, 2022
Prostate Adenocarcinoma Trial in Tucson (F-18 fluciclovine-PET/CT scan)
Completed
- Prostate Adenocarcinoma
- F-18 fluciclovine-PET/CT scan
-
Tucson, ArizonaUniversity of Arizona
Aug 12, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)
Recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 23, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a
Recruiting
- Prostate Cancer
- +4 more
- Performing cognitive prostate biopsy with a radiologist's guidance with map
- Performing cognitive prostate biopsy without a radiologist's guidance with map
-
Istanbul, TurkeyMarmara University, School of Medicine, Department of Urology
Jun 5, 2023
Prostate Disease, Malignancy, Benign Prostatic Hyperplasia Trial in Boston (Self-Administered Nitrous Oxide, Oxygen)
Completed
- Prostate Disease
- +6 more
- Self-Administered Nitrous Oxide
- Oxygen
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 25, 2023
Prostate Adenocarcinoma Trial in Valence, Clermont-Ferrand, Lyon (Integrated boost)
Recruiting
- Prostate Adenocarcinoma
- Integrated boost
-
Valence, Drôme, France
- +3 more
Oct 26, 2022
Prostatic Tumor, Adenocarcinoma, Tumor Recurrence Trial in Rennes, Pointe-à-Pitre (Standard care)
Recruiting
- Prostatic Neoplasm
- +3 more
- Standard care
-
Rennes, Ille-et-Vilaine, France
- +1 more
Sep 14, 2023
Prostate Cancer, Adenocarcinoma, Prostatic Tumors Trial (bpMRI, Image-Fusion targeted and systematic Biopsy)
Not yet recruiting
- Prostate Cancer
- +4 more
- bpMRI
- Image-Fusion targeted and systematic Biopsy
- (no location specified)
Oct 7, 2022
Prostatic Tumors, Castration-Resistant Trial in Brisbane ([212Pb]Pb-ADVC001)
Not yet recruiting
- Prostatic Neoplasms
- Castration-Resistant
-
Brisbane, Queensland, AustraliaRoyal Brisbane & Women's Hospital
Feb 9, 2023
Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
- Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 4, 2023
Adenocarcinoma of the Prostate Trial in Washington, Baltimore, Bethesda (Radiation Therapy, Androgen Deprivation Therapy (ADT))
Active, not recruiting
- Adenocarcinoma of the Prostate
- Radiation Therapy
- Androgen Deprivation Therapy (ADT)
-
Washington, District of Columbia
- +2 more
Oct 25, 2022
Prostate Cancer Trial in Baltimore (hypofractionation)
Active, not recruiting
- Prostate Cancer
- hypofractionation
-
Baltimore, MarylandThe Johns Hopkins University School of Medicne
Mar 18, 2022
Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in San Francisco (High Dose Rate Monotherapy)
Not yet recruiting
- Prostate Adenocarcinoma
- Localized Prostate Carcinoma
- High Dose Rate Monotherapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 27, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC
Recruiting
- Prostate Adenocarcinoma
- +7 more
- High-Dose Rate Brachytherapy
- Stereotactic Body Radiation Therapy
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022